Elekta AB ADR | Cash Flow

Fiscal year is May-April. All values SEK Millions.
2014
2015
2016
2017
2018
2019
Net Income before Extraordinaries
1,502
716
189
340
1,375
1,580
Depreciation, Depletion & Amortization
414
512
634
655
675
279
Other Funds
7
-
5
10
-
397
Funds from Operations
1,692
1,299
708
768
2,052
2,256
Changes in Working Capital
417
524
461
1,051
351
636
Net Operating Cash Flow
1,275
1,823
1,169
1,819
2,403
1,620
Capital Expenditures
726
982
783
774
854
Sale of Fixed Assets & Businesses
1
6
14
-
38
Purchase/Sale of Investments
4
-
12
6
96
Net Investing Cash Flow
777
1,144
786
792
957
Cash Dividends Paid - Total
763
769
191
191
382
Issuance/Reduction of Debt, Net
85
955
1,107
167
-
Net Financing Cash Flow
888
186
1,303
55
367
Net Change in Cash
320
1,018
992
1,110
1,075
Free Cash Flow
1,041
1,526
982
1,678
2,191
Net Assets from Acquisitions
-
191
24
24
45
Other Sources
7
35
7
-
-
Change in Capital Stock
33
-
-
21
-
Exchange Rate Effect
70
153
72
138
4
Other Uses
63
12
12
-
-

About Elekta AB

View Profile
Address
Kungstensgatan 18
Stockholm SD 103 93
Sweden
Employees -
Website http://www.elekta.com
Updated 07/08/2019
Elekta AB engages in the provision of clinical solutions for the treatment of cancers and brain disorders. Its products and solutions include radiotherapy, stereotactic radiosurgery, oncology informatics, brachytheraphy, neurosurgery, and particle therapy. It operates through the following geographical segments: North and South America; Europe.